NEDD4L and neoplasm: Since IL-17R signaling can affect IEC homeostasis, differentiation, and tumor development (38–40), we tested whether NEDD4L regulates DSS-induced colitis through IL-17R signaling by using an IL-17 neutralizing antibody.